Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?

被引:3
作者
Shapter, Frances Marie [1 ]
Granados-Soler, Jose Luis [1 ]
Stewart, Allison J. J. [1 ]
Bertin, Francois Rene [1 ]
Allavena, Rachel [1 ]
机构
[1] Univ Queensland Gatton, Sch Vet Sci, 5391 Warrego Highway, Gatton, Qld 4343, Australia
来源
ANIMALS | 2023年 / 13卷 / 13期
关键词
horse; lung; fibrosis; pneumonia; toxic plant; pulmonary fibrosis; dyspnea; Ageratina; Eupatorium; EUPATORIUM-ADENOPHORUM TOXICITY; INTERSTITIAL PNEUMONIA; PYRROLIZIDINE ALKALOIDS; CADINENE SESQUITERPENES; BIOLOGICAL-CONTROL; HEPATOTOXICITY; HORSES; EUPTOX; POLLEN; 9-OXO-10,11-DEHYDROAGERAPHORONE;
D O I
10.3390/ani13132082
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary Crofton weed toxicity, caused by Ageratina adenophora, has been recognized as a cause of fatal lung disease in horses for over a century. Despite its impact on horse health in many areas of the world, the toxic syndrome is poorly understood and understudied. This paper looks at the prior research on weed biology, the potential toxicology mechanisms, and the pathology in horses and other species, as well as the future directions to improve our understanding of this fatal toxic weed affecting horses. Crofton weed (Ageratina adenophora) is a global and highly invasive weed, with ingestion causing severe respiratory disease in horses, leading to irreversible and untreatable pulmonary fibrosis and oedema. While reports of equine pneumotoxicity remain common in Australia and New Zealand, equine pneumotoxicity may be underdiagnosed in other countries where Crofton weed is endemic but poorly differentiated. The pathogenesis of Crofton weed toxicity following ingestion has been well described in a number of different animal models, including rodents, rabbits, and goats. However, induced toxicity is organ-selective across different animal species, and these vastly differ from the pathogenesis described in horses, both clinically and after experimental exposure. Sources of variation may include species-specific susceptibility to different toxins present in the plant, different mechanistic processes of toxicity, and species differences in toxin biotransformation and bioactivation across different organs. Considering disease severity and Crofton weed's invasiveness globally, assessing published toxicological and exposure data is necessary to advance research, identify specific toxins for horses, and possible prophylactic and therapeutic strategies. This review presents an overview of the available literature on equine toxicity, parallels between toxicity in horses and other animal species, and important aspects to be included in the future research agenda.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The weevil-watermilfoil interaction at different spatial scales: What we know and what we need to know
    Creed, RP
    [J]. JOURNAL OF AQUATIC PLANT MANAGEMENT, 2000, 38 : 78 - 81
  • [22] Pollen priming for more efficient reproduction in a heating world: what we know, what we need to know
    Mareri, Lavinia
    Cai, Giampiero
    [J]. PLANT STRESS, 2022, 3
  • [23] Skin Barrier in Normal and Allergic Horses: What Do We Know?
    Marsella, Rosanna
    [J]. VETERINARY SCIENCES, 2025, 12 (02)
  • [24] Asthma and COVID-19: What do we know now
    Hughes-Visentin, Alexzandra
    Paul, Anthea B. Mahesan
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
  • [25] Biological Control of Indigenous African Stemborers: What Do We Know?
    D. E. Conlong
    [J]. International Journal of Tropical Insect Science, 2001, 21 (4) : 267 - 274
  • [26] COVID-19 in dental care: What do we know?
    Chmielewski, Marek
    Zalachowska, Oliwia
    Rybakowska, Weronika
    Komandera, Dominika
    Knura, Agata
    Albert, Adrian
    Kostanowicz, Julia
    Garbacz, Katarzyna
    [J]. JOURNAL OF ORAL MICROBIOLOGY, 2021, 13 (01)
  • [27] Vasculitis and COVID-19: what do we have to know?
    Tamburello, Antonio
    Castelno, Laura
    Bizzi, Emanuele
    Caso, Francesco
    [J]. ITALIAN JOURNAL OF MEDICINE, 2020, 14 (04) : 213 - 215
  • [28] A Copernican response: To know what we know
    Niroomand, Anna
    Hyllen, Snejana
    Lindstedt, Sandra
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2022, 66 (05) : 653 - 654
  • [29] What Do We Know About Clodronate Now? A Medical and Veterinary Perspective
    Markell, Richard
    Saviola, Gianantonio
    Barker, Elizabeth Ann
    Conway, James Daniel
    Dujardin, Chris
    [J]. JOURNAL OF EQUINE VETERINARY SCIENCE, 2020, 88
  • [30] COVID-19 and the liver: What do we know so far?
    Nasa, Prashant
    Alexander, George
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (05) : 522 - 532